Ознакомительная версия. Доступно 15 страниц из 73
67. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and cancer: fact or fiction? European Journal of Cancer 1999; 35: 1603–7.
68. Antonijevic IA. Depressive disorders – is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006; 31: 1–15.
69. Riley V. Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 1975; 189: 465–7.
70. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 1981; 212: 1100–9.
71. Sapolsky RM, Donnelly TM. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology 1985; 117: 662–6.
72. Sapolsky R, Krey L, McEwan BS. Prolonged glucocorticoidexposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985; 5: 1222–1227.
73. Jayo JM, Shively CA, Kaplan JR, et al. Effects of exercise and stress on body fat distribution in male cynomolgus monkeys. Interbational Journal of Obesity&Related Metabolic Disorders 1993; 17: 597–604.
74. Epel E, McEwen B, Seeman T, et al. Psychological stress and lack of cortisol habituation among women with abdominal fat distribution. Psychosom Med 1999; 61:107.
75. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998; 21: 293–307.
76. Posener JA, Schildkraut JJ, Samson JA, et al. Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology 1996; 21: 33–8.
77. David Spiegel. Mind matters in cancer survival. Psychooncology 2012; 21(6): 588–593.
78. Sheridan JF, Dobbs C, Jung J, et al. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann N Y Acad Sci 1998; 840: 803–8.
79. Sheridan JF. Stress-induced modulation of anti-viral immunity – Normal Cousins Memorial Lecture 1997; Brain, Behav, Immun 1998; 12: 1–6.
80. Padgett DA, Loria RM, Sheridan JF. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J Neuroimmunol 1997; 78: 203–11.
81. Glaser R, Kiecolt-Glaser JK. Stress associated immune modulations: relevance to viral infections and chronic fatigue syndrome. American Journal of Medicine 1998; 105: 35S–42S.
82. Kiecolt-Glaser JK, Glaser R, Cacioppo JT, et al. Marital stress: immunologic, neuroendocrine, and autonomic correlates. Ann N Y Acad Sci 1998; 840: 656–63.
83. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility too the common cold. N Engl J Med 1991; 325: 606–12.
84. Garssen B, Goodkin K. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psyciatry Res 1999; 85: 51–61.
85. Reynolds P, Hurley S, Torres M, Jackson J, Boyd P, Chen VW. Use of coping strategies and breast cancer survival: results from the Black/White cancer survival study. Am J Epidemiol 2000; 152: 940–948.
86. Garssen B, Remie M. Different concepts or different words? Concepts related to non-expression of negative emotions. In Emotional Expression and Health 2004, Nyclicek I, Temoshok L, Vingerhoets A, pp 117–136. Hove and New York: Brunner-Routledge.
87. Butow PN, Coates AS, Dunn S. Psychosocial predictors of survival: metastatic breast cancer. Ann Oncol 2000; 11: 469–474.
88. Butow PN, Coates AS, Dunn SM. Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol 1999; 17: 2256–2263.
89. Folkman S, Chesney M, McKusick L, Ironson G, Johnson DS, Coates TJ. Translating coping theory into an intervention. In: The Social Context of Coping, Eckenrode J, pp 239–260. New York: Plenum Press.
90. Burgess C. Stress and cancer. Cancer Surv 1987; 6: 403–416.
91. Temoshok L. Personality, coping style, emotion and cancer: towards an integrative model. Cancer Surv 1987; 6: 545–567.
92. Dolbeaut S, Szporn A, Holland JC. Psycho-oncology: where have we been? Where are we going? Eur J Cancer 1999; 35: 1554–1558.
93. Gross J. Emotional expression in cancer onset and progression. Soc Sci Med 1989; 28: 1239–1248.
94. Greer S, Watson M. Towards a psychobiological model of cancer: psychological considerations. Soc Sci Med 1985; 20: 773–777.
95. Petticrew M, Bell R, Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ 2002; 325: 1066–1069.
96. Grossarth-Maticek R, Bastiaans J, Kanazir DT. Psychosocial factors as strong predictors of mortality from cancer, ischaemic heart disease and stroke: the Yugoslav prospective study. J Psychosom Res 1985; 29: 167–176.
97. van der Plog HM, Kleijn WC, Mook J, van Donge M, Pieters AMJ, Leer J-WH. Rationality and antiemotionality as a risk factor for cancer: concepts differentiation. J Psychosom Res 1989; 33: 217–225.
98. Swan G, Carmelli D, Dame A, Rosenman R, Spielberger C. The rationality/emotional defensiveness scale II. Convergent and discriminant correlational analysis in males and females with and without cancer. J Psycosom Res 1992; 36: 349–359.
99. U-S Lehto, M Ojanen, T Dyba, A Aromaa and P Kellokumpu-Lehtinen. Baseline psycosocial predictors of survival in localized breast cancer. British J of Cancer 2006; 94: 1245–1252.
100. Zozulya AA, Gabaeva MV, Sokolov OY, Surkina ID, Kost NV. Personality, coping style, and constitutional neuroimmunology. J Immunotoxicology 2008; 5(2): 221–5.
Глава 12. Скрининг и методы обследования для ранней диагностики рака
Под скринингом понимают применение различных методов обследования, позволяющих диагностировать опухоль на ранней стадии, когда еще нет симптомов болезни. Целью скрининга является раннее активное выявление бессимптомного рака и его лечение.
Главный принцип профилактики и попыток «диагностировать рак» заключается в том факте, что качество жизни здоровых людей не может быть улучшено медициной, но легко может быть ею испорчено!
То есть, не надо специально «искать» или ежегодно предпринимать ряд обследований, чтобы «найти, что не в порядке». Постарайтесь наслаждаться здоровьем, а не искать болезнь.
Однако для некоторых типов рака это правило не работает, и скрининг определенной группы людей для «поиска» ранних стадий рака организовывается за счет государства, так как доказал свою пользу.
Ознакомительная версия. Доступно 15 страниц из 73
